Partners
 |
 |
 |
 |
 |
HJFMRI is proud to partner with organizations from across the globe. These organizations include host country governments, public institutions, private entities, universities, and foundations to advance global health. HJFMRI’s funders and collaborators number in the hundreds, and major partners include:
U.S. Army Medical Research Directorate - Africa (USAMRD-A)
Since 2010, HJFMRI has served as the managing partner for the U.S. Government-funded Overseas Support Activities for the United States (U.S.) Army Medical Research Directorate – Africa’s (USAMRD-A) Infectious Disease Surveillance Program in Sub-Saharan Africa.
This program has implemented surveillance research and outbreak response activities in Uganda, Tanzania, and Kenya and across other Sub-Saharan African nations in collaboration with the Kenya Medical Research Institute (KEMRI), Makerere University–Walter Reed Project (MUWRP), and Stichting PharmAccess International (PAI).
U.S. Military HIV Research Program (MHRP)
HJF has partnered with the U.S. Military HIV Research Program (MHRP) at the Walter Reed Army Institute of Research (WRAIR) since its inception in 1986. This program has emerged as a world leader in HIV vaccine research and development, global epidemiology, HIV remission strategies, and threat assessment, and HJFMRI has been a key partner in the expansion and implementation of global research.
HJFMRI conducts medical research and implements HIV prevention and treatment programs alongside local partners in each of the communities in which MHRP conducts research with support from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). HJFMRI has built extensive military, academic, NGO, and private industry partnerships throughout the world to support this program.
Emerging Infectious Diseases Branch (EIDB)
HJF and HJFMRI have provided critical support for emerging diseases research to the Walter Reed Army Institute of Research (WRAIR) for many years, including studies on vaccines for Ebola, Anthrax, Marburg and Zika. In 2018, WRAIR established the Emerging Infectious Diseases Branch (EIDB) with an explicit mission to survey, anticipate and counter the mounting threat of emerging infectious diseases of key importance to U.S. forces in the homeland and abroad.
Building on broad, clinical research expertise and international infrastructure, HJF and HJFMRI have helped positioned WRAIR to rapidly respond to the accelerating threats posed by emerging infectious diseases including COVID-19, Ebola, Lassa and Monkeypox with local military, academic and many other collaborators.
Austere Environments Consortium for Enhanced Sepsis Outcomes (ACESO)
The Austere Environments Consortium for Enhanced Sepsis Outcomes (ACESO) is a partnership of military medical, nonprofit, industry, and academic research partners from around the world with the aim of improving early recognition, diagnosis and treatment of sepsis. Using data from its clinical research platforms, ACESO employs a multi-omics systems biology approach to identify host-response biomarkers that are either diagnostic of sepsis phenotypes or predictive of clinical severity, and which can ultimately be translated onto deployable point-of-care (POC) devices. In addition, ACESO is partnering on multiple COVID-19 studies aiming to better define the natural history of disease, work on therapeutics, develop predictive algorithms to guide clinical decision-making, and deploy novel technologies.
Kenya Medical Research Institute (KEMRI)
HJFMRI helped launched an international HIV vaccine research program in collaboration with the Kenya Medical Research Institute (KEMRI) based in Kericho, Kenya. The program has developed expertise and infrastructure to support vaccine, therapeutic and other infectious disease research. HJFMRI also works with a KEMRI satellite clinic, the Kombewa Clinical Research Centre, in Kisumu County.
HJFMRI also supports KEMRI’s Center for Global Health Research (CGHR) campus in Western Kenya. HJFMRI’s team strengthens KEMRI’s research initiatives and leads various Tuberculosis, Influenza and HIV research studies being conducted in Western Kenya by the U.S. CDC.
Child Health and Mortality Prevention Surveillance Network (CHAMPS)
CHAMPS was established to develop a network of high-quality sites to collect robust and standardized longitudinal data, with the overarching objective of understanding and tracking the preventable causes of childhood death globally. HJFMRI participates in several studies in Africa through this network, around pregnancy, early childhood health, and COVID-19. The CHAMPS Network Program Office leads the network under the direction of the Emory Global Health Institute and project is funded through a grant from the Bill and Melinda Gates Foundation.
NIH-funded Clinical Trial Networks
HJFMRI works with many partners in the United States and Africa to execute clinical studies funded through the U.S. National Institutes of Health. The NIAID/NIH networks HJFMRI supports include the AIDS Clinical Trails Group (ACTG), HIV Prevention Trials Network (HPTN) and COVID-19 Prevention Network (CoVPN)-funded trials. In 2021 HJFMRI began supporting CoVPN vaccine studies in Kenya.